Blood cancers

When is it clinically relevant to use PET in lymphoma?

Sponsored by Janssen-Cilag Pty Ltd

A baseline PET-CT scan (PET) is a more sensitive staging modality than standard contrast enhanced CT scanning in lymphoma patients, obviating the need for bone marrow biopsy in patients with Hodgkin’s lymphoma (HL) and most with diffuse large B-cell lymphoma (DLBCL). It can also be used at the end of induction after first line therapy to ...

Already a member?

Login to keep reading.

© 2021 the limbic